Literature DB >> 25442136

Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata.

Sean R Dariushnia1, Boris Nikolic2, LeAnn S Stokes3, James B Spies4.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25442136     DOI: 10.1016/j.jvir.2014.08.029

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  7 in total

Review 1.  Updates on Uterine Artery Embolization.

Authors:  Maureen P Kohi; James B Spies
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

Review 2.  Fibroid Expulsion after Uterine Artery Embolization.

Authors:  Emily Ochmanek; Matthew A Brown; Paul J Rochon
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

Review 3.  Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy.

Authors:  Krisztina Fischer; Nathan J McDannold; Clare M Tempany; Ferenc A Jolesz; Fiona M Fennessy
Journal:  Int J Womens Health       Date:  2015-11-13

Review 4.  Uterine fibroids - what's new?

Authors:  Alistair R W Williams
Journal:  F1000Res       Date:  2017-12-07

5.  Initial experience with HydroPearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids.

Authors:  Matthew A Patetta; Ari J Isaacson; Jessica K Stewart
Journal:  CVIR Endovasc       Date:  2021-03-31

6.  Efficacies of uterine artery embolization for symptomatic uterine fibroids using gelatin sponge: a single-center experience and literature review.

Authors:  Aska Toda; Kenjiro Sawada; Keigo Osuga; Noboru Maeda; Hiroki Higashihara; Tomoyuki Sasano; Noriyuki Tomiyama; Tadashi Kimura
Journal:  Int J Womens Health       Date:  2016-08-12

7.  Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases.

Authors:  Man Deuk Kim
Journal:  Korean J Radiol       Date:  2019-10       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.